Diphtheria, Tetanus, and Pertussis (DTP) Vaccines Market Size, Share & Industry Analysis, By Technology (Inactivated and Others), By Type (DTaP Vaccine, Tdap Vaccine, DT/Td Vaccine, and Others) By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113648

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Countries, 2024
2. Key Industry Developments (Launches, Mergers, Acquisitions, Partnerships, etc.)
3. Pipeline Analysis, By Key Players
4. Overview: Vaccination Coverage for Diphtheria Tetanus and Pertussis (DTP) Vaccines, By Key Countries
Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Boryung Biopharma Co.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Wuhan Institute of Biological Products Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. BioNet-Asia.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Biological E Limited.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Countries, 2024
2. Key Industry Developments (Launches, Mergers, Acquisitions, Partnerships, etc.)
3. Pipeline Analysis, By Key Players
4. Overview: Vaccination Coverage for Diphtheria Tetanus and Pertussis (DTP) Vaccines, By Key Countries
Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Inactivated
  2. Others
2. Market Analysis, Insights and Forecast – By Type
  1. DTaP Vaccine
  2. Tdap Vaccine
  3. DT/ Td vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adolts
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Boryung Biopharma Co.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Wuhan Institute of Biological Products Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. BioNet-Asia.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Biological E Limited.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024 & 2032

Figure 3: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024 & 2032

Figure 4: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group 2024 & 2032

Figure 5: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 6: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 7: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Technology, 2024 & 2032

Figure 8: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024

Figure 9: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 10: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024

Figure 11: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 12: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group, 2024

Figure 13: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 14: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 15: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), By Country, 2024

Figure 17: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Technology, 2024 & 2032

Figure 18: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024

Figure 19: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 20: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024

Figure 21: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 22: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group, 2024

Figure 23: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 24: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 25: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 26: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 27: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Technology, 2024 & 2032

Figure 28: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024

Figure 29: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 30: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024

Figure 31: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 32: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group, 2024

Figure 33: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 35: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 36: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 37: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Technology, 2024 & 2032

Figure 38: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024

Figure 39: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 40: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024

Figure 41: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 42: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group, 2024

Figure 43: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 44: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 45: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 46: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 47: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Technology, 2024 & 2032

Figure 48: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Technology, 2024

Figure 49: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 50: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Type, 2024

Figure 51: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 52: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Age Group, 2024

Figure 53: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 55: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 56: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 57: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 2: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2033

Table 3: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2034

Table 4: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 5: Global Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 7: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 8: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 9: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 10: North America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 12: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 13: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 14: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 15: Europe Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 16: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 17: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 18: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 19: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 20: Asia Pacific Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 21: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 22: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 23: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 24: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 25: Latin America Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 26: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 27: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 28: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 29: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 30: Middle East & Africa Diphtheria Tetanus and Pertussis (DTP) Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032